ClearPoint Neuro(CLPT)
$8.48-0.01 (-0.12%)
CLPT
ClearPoint Neuro financials statements
$8.48
At close:-0.01 (-0.12%)
Want to see CLPT full AI Analyst Report?
ClearPoint Neuro (CLPT) Ratios
454 Followers
ClearPoint Neuro Ratios
CLPT's free cash flow for Q3 2026 was $-5.25M. For the 2026 fiscal year, CLPT's free cash flow was decreased by $-137.00K and operating cash flow was $-5.11M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 5.91 | 3.22 | 4.87 | 7.54 | 13.02 |
| Quick Ratio | 5.13 | 2.56 | 3.80 | 6.17 | 11.98 |
| Cash Ratio | 4.27 | 1.94 | 3.11 | 4.07 | 11.38 |
| Solvency Ratio | -0.33 | -1.23 | -0.96 | -0.84 | -0.82 |
| Operating Cash Flow Ratio | -2.22 | -0.86 | -1.85 | -2.38 | -2.67 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -6.13M | $ 19.56M | $ 14.68M | $ 32.58M | $ 45.10M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.60 | 0.09 | 0.33 | 0.22 | 0.19 |
| Debt-to-Equity Ratio | 2.08 | 0.14 | 0.66 | 0.32 | 0.25 |
| Debt-to-Capital Ratio | 0.68 | 0.12 | 0.40 | 0.25 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.64 | 0.00 | 0.32 | 0.21 | 0.17 |
| Financial Leverage Ratio | 3.49 | 1.54 | 2.01 | 1.50 | 1.34 |
| Debt Service Coverage Ratio | -8.76 | 0.00 | 0.00 | -192.31 | -13.10 |
| Interest Coverage Ratio | -10.12 | 0.00 | 0.00 | -201.63 | -13.75 |
| Debt to Market Cap | 0.13 | 0.00 | 0.06 | 0.05 | 0.04 |
| Interest Debt Per Share | 2.14 | 0.13 | 0.57 | 0.50 | 0.64 |
| Net Debt to EBITDA | -0.59 | 0.97 | 0.44 | 1.00 | 3.28 |
| Profitability Margins | |||||
| Gross Profit Margin | 61.38% | 60.92% | 56.83% | 65.84% | 68.24% |
| EBIT Margin | -62.47% | -60.25% | -93.70% | -79.58% | -82.44% |
| EBITDA Margin | -56.42% | -54.19% | -87.62% | -75.80% | -78.19% |
| Operating Profit Margin | -65.36% | -62.91% | -93.70% | -79.47% | -82.05% |
| Pretax Profit Margin | -68.93% | -60.25% | -92.21% | -79.97% | -88.41% |
| Net Profit Margin | -69.08% | -60.25% | -92.21% | -79.97% | -88.41% |
| Continuous Operations Profit Margin | -69.08% | -60.25% | -92.21% | -79.97% | -88.41% |
| Net Income Per EBT | 100.22% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 105.47% | 95.79% | 98.41% | 100.63% | 107.75% |
| Return on Assets (ROA) | -26.13% | -48.26% | -51.78% | -29.62% | -21.97% |
| Return on Equity (ROE) | -91.15% | -74.50% | -104.33% | -44.55% | -29.54% |
| Return on Capital Employed (ROCE) | -27.78% | -68.48% | -63.71% | -33.53% | -21.99% |
| Return on Invested Capital (ROIC) | -27.56% | -67.18% | -62.95% | -33.15% | -21.80% |
| Return on Tangible Assets | -33.45% | -48.87% | -53.07% | -30.18% | -22.06% |
| Earnings Yield | -6.59% | -4.55% | -13.22% | -8.02% | -6.19% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.09 | 6.66 | 6.07 | 7.71 | 6.97 |
| Payables Turnover | 11.37 | 9.16 | 26.31 | 25.81 | 12.12 |
| Inventory Turnover | 1.71 | 1.79 | 1.31 | 0.75 | 1.05 |
| Fixed Asset Turnover | 3.35 | 6.17 | 4.84 | 7.61 | 5.86 |
| Asset Turnover | 0.38 | 0.80 | 0.56 | 0.37 | 0.25 |
| Working Capital Turnover Ratio | 0.97 | 1.21 | 0.66 | 0.40 | 0.41 |
| Cash Conversion Cycle | 253.27 | 219.12 | 325.45 | 516.89 | 370.44 |
| Days of Sales Outstanding | 71.70 | 54.80 | 60.09 | 47.33 | 52.33 |
| Days of Inventory Outstanding | 213.67 | 204.19 | 279.23 | 483.70 | 348.22 |
| Days of Payables Outstanding | 32.11 | 39.87 | 13.87 | 14.14 | 30.11 |
| Operating Cycle | 285.38 | 258.99 | 339.32 | 531.04 | 400.55 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.84 | -0.33 | -0.56 | -0.67 | -0.61 |
| Free Cash Flow Per Share | -0.86 | -0.34 | -0.59 | -0.68 | -0.62 |
| Dividend Paid and CapEx Coverage Ratio | -45.83 | -32.55 | -19.14 | -63.90 | -75.58 |
| Capital Expenditure Coverage Ratio | -45.83 | -32.55 | -19.14 | -63.90 | -75.58 |
| Operating Cash Flow Coverage Ratio | -0.41 | -2.51 | -0.98 | -1.35 | -1.03 |
| Operating Cash Flow to Sales Ratio | -0.65 | -0.29 | -0.57 | -0.79 | -0.78 |
| Free Cash Flow Yield | -6.31% | -2.22% | -8.64% | -8.02% | -5.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -15.20 | -21.97 | -7.56 | -12.46 | -16.14 |
| Price-to-Sales (P/S) Ratio | 10.48 | 13.24 | 6.97 | 9.97 | 14.27 |
| Price-to-Book (P/B) Ratio | 13.82 | 16.37 | 7.89 | 5.55 | 4.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -15.84 | -45.06 | -11.57 | -12.47 | -18.08 |
| Price-to-Operating Cash Flow Ratio | -16.19 | -46.45 | -12.18 | -12.67 | -18.32 |
| Price-to-Earnings Growth (PEG) Ratio | -0.53 | 0.99 | -0.23 | 8.60 | -0.27 |
| Enterprise Value Multiple | -19.16 | -23.46 | -7.52 | -12.15 | -14.97 |
| Enterprise Value | 399.66M | 399.15M | 157.87M | 189.19M | 190.81M |
| EV to EBITDA | -19.16 | -23.46 | -7.52 | -12.15 | -14.97 |
| EV to Sales | 10.81 | 12.72 | 6.59 | 9.21 | 11.71 |
| EV to Free Cash Flow | -16.35 | -43.27 | -10.94 | -11.52 | -14.83 |
| EV to Operating Cash Flow | -16.70 | -44.60 | -11.51 | -11.70 | -15.03 |
| Tangible Book Value Per Share | 0.23 | 0.92 | 0.82 | 1.48 | 2.34 |
| Shareholders’ Equity Per Share | 0.99 | 0.94 | 0.86 | 1.53 | 2.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 1.31 | 1.16 | 0.97 | 0.85 | 0.79 |
| Net Income Per Share | -0.90 | -0.70 | -0.90 | -0.68 | -0.69 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.10 | 1.00 | 0.98 | 1.00 | 1.07 |
| Research & Development to Revenue | 0.38 | 0.39 | 0.49 | 0.53 | 0.57 |
| SG&A to Revenue | 0.89 | 0.84 | 0.49 | 0.47 | 0.49 |
| Stock-Based Compensation to Revenue | 0.22 | 0.22 | 0.25 | 0.00 | 0.13 |
| Income Quality | 0.94 | 0.47 | 0.62 | 0.98 | 0.88 |
Currency in USD

